Author:
Nørgaard Jan M,Olesen Lene H,Olesen Gitte,Meyer Karin,Kristensen Jørgen S,Bendix Knud,Pedersen Bent,Kjeldsen Eigil,Hokland Peter
Subject
Hematology,General Medicine
Reference35 articles.
1. All-trans retinoic acid (ATRA) therapeutical effect in acute promyelocytic leukemia;Degos;Biomed Pharmacother,1992
2. In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cells;Calabresse;Leukemia,1995
3. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties;Wheatley;Br J Haematol,1999
4. Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin;Taub;Blood,1999
5. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498;Ravindranath;Blood,1992
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献